The ability to harness real-world insights at scale empowers life sciences companies and clinicians to develop more targeted therapies, improve patient outcomes, and drive evidence-based innovation in BPH treatment.
Y Combinator graduate Zenflow has raised a $31.4 million Series A following a successful human trial of its Spring System in patients with benign prostatic hyperplasia (BPH) or enlarged prostate.
AI-native tax firm Gelt combines top human tax experts with AI to help physicians and healthcare practices use data-driven tax strategies to lower liabilities, improve profitability, and future-proof their finances.